Evidence map›Paper›PMID 33044007›Full record

ArticleThe oncologist2021

The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives.

Nicola Rocco, Giacomo Montagna, Rosa Di Micco, John Benson, Carmen Criscitiello, Li Chen, Bruno Di Pace, Antonio Jesus Esgueva Colmenarejo, Yves Harder, Andreas Karakatsanis and 9 more

Abstract read
In one paragraph

Article in The oncologist, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Breast cancer care amidst a pandemic: a scoping review to understand the impact of coronavirus disease 2019 on health services and health outcomes.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nicola RoccoGroup for Reconstructive and Therapeutic Advancements (G.Re.T.A.), Milan, Naples, Catania, Italy.ORCID 0000-0001-6941-7873
Giacomo MontagnaBreast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Rosa Di MiccoBreast Surgery, San Raffaele University and Research Hospital, Milan, Italy.
John BensonAddenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Carmen CriscitielloEuropean Institute of Oncology (IEO) IRCCS, Milan, Italy.
Li ChenBreast Center, Southwest Hospital, China Army Medical University, Chongqing, People's Republic of China.
Bruno Di PaceSchool of Medicine, Anglia Ruskin University, Cambridge, United Kingdom.
Antonio Jesus Esgueva ColmenarejoBreast Cancer Unit, Clinica Universidad de Navarra, Madrid, Spain.
Yves HarderDepartment of Plastic, Reconstructive and Aesthetic Surgery, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Andreas KarakatsanisSection for Breast Surgery, Department of Surgery, Uppsala University Hospital, Uppsala, Sweden.
Anna MagliaMultidisciplinary Breast Unit, Azienda Ospedaliera Cannizzaro, Catania, Italy.
Marco MeleBreast Surgery Department, Herlev and Gentofte Hospital, Copenhagen, Denmark.
Nahid NafissiDepartment of Breast Surgery, Iran University of Medical Sciences, Tehran, Iran.
Pedro Santos FerreiraBreast Unit, Setubal Medical Center, Setúbal, Portugal.
Wafa TaherBreast Surgery, Northampton General Hospital, Northampton, United Kingdom.
Antonio TejerinaBreast Surgery Department, Centro de Patología de la Mama, Fundación Tejerina, Madrid, Spain.
Alessio VinciDepartment of Breast Surgery, Ninewells Hospital and Medical School, Dundee, Scotland, United Kingdom.
Maurizio NavaGroup for Reconstructive and Therapeutic Advancements (G.Re.T.A.), Milan, Naples, Catania, Italy.
Giuseppe CatanutoGroup for Reconstructive and Therapeutic Advancements (G.Re.T.A.), Milan, Naples, Catania, Italy.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

introductionThe rapid spread of COVID-19 across the globe is forcing surgical oncologists to change their daily practice. We sought to evaluate how breast surgeons are adapting their surgical activity to limit viral spread and spare hospital resources.

methodsA panel of 12 breast surgeons from the most affected regions of the world convened a virtual meeting on April 7, 2020, to discuss the changes in their local surgical practice during the COVID-19 pandemic. Similarly, a Web-based poll based was created to evaluate changes in surgical practice among breast surgeons from several countries.

resultsThe virtual meeting showed that distinct countries and regions were experiencing different phases of the pandemic. Surgical priority was given to patients with aggressive disease not candidate for primary systemic therapy, those with progressive disease under neoadjuvant systemic therapy, and patients who have finished neoadjuvant therapy. One hundred breast surgeons filled out the poll. The trend showed reductions in operating room schedules, indications for surgery, and consultations, with an increasingly restrictive approach to elective surgery with worsening of the pandemic.

conclusionThe COVID-19 emergency should not compromise treatment of a potentially lethal disease such as breast cancer. Our results reveal that physicians are instinctively reluctant to abandon conventional standards of care when possible. However, as the situation deteriorates, alternative strategies of de-escalation are being adopted. IMPLICATIONS FOR PRACTICE: This study aimed to characterize how the COVID-19 pandemic is affecting breast cancer surgery and which strategies are being adopted to cope with the situation.

Indexed as

Appointments and SchedulesBreast NeoplasmsCommunicable Disease ControlCOVID-19Disease ProgressionElective Surgical ProceduresFemaleGlobal Burden of DiseaseHealth Care RationingHumansMastectomyNeoadjuvant TherapyOperating RoomsPandemicsPatient SelectionPersonnel Staffing and SchedulingAlternatives to surgeryBreast cancer surgeryCOVID-19Surgical prioritiesTriage

Identifiers

PMID33044007
PMCPMC7675306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.